Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples